Willemse MJ - Search Results

1

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

Biondi A, Valsecchi MG, Seriu T, D'Aniello E, Willemse MJ, Fasching K, Pannunzio A, Gadner H, Schrappe M, Kamps WA, Bartram CR, van Dongen JJ, Panzer-Grümayer ER. Biondi A, et al. Among authors: willemse mj. Leukemia. 2000 Nov;14(11):1939-43. doi: 10.1038/sj.leu.2401922. Leukemia. 2000. PMID: 11069029

2

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: willemse mj. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681

3

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Grümayer ER, Biondi A, Schrappe M, Kamps WA, Masera G, Gadner H, Riehm H, Bartram CR, van Dongen JJ. Willemse MJ, et al. Blood. 2002 Jun 15;99(12):4386-93. doi: 10.1182/blood.v99.12.4386. Blood. 2002. PMID: 12036866 Free article.

4

T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring.

Szczepański T, Langerak AW, Willemse MJ, Wolvers-Tettero IL, van Wering ER, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Leukemia. 2000 Jul;14(7):1208-14. doi: 10.1038/sj.leu.2401765. Leukemia. 2000. PMID: 10914544

5

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease.

van Wering ER, van der Linden-Schrever BE, Szczepański T, Willemse MJ, Baars EA, van Wijngaarde-Schmitz HM, Kamps WA, van Dongen JJ. van Wering ER, et al. Among authors: willemse mj. Br J Haematol. 2000 Jul;110(1):139-46. doi: 10.1046/j.1365-2141.2000.02143.x. Br J Haematol. 2000. PMID: 10930991 Free article.

6

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.

Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Among authors: willemse mj. Leukemia. 2000 Aug;14(8):1426-35. doi: 10.1038/sj.leu.2401801. Leukemia. 2000. PMID: 10942239

7

Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14.

Szczepański T, Willemse MJ, van Wering ER, van Weerden JF, Kamps WA, van Dongen JJ. Szczepański T, et al. Among authors: willemse mj. Leukemia. 2001 Sep;15(9):1415-23. doi: 10.1038/sj.leu.2402206. Leukemia. 2001. PMID: 11516102

8

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia.

van der Velden VH, Joosten SA, Willemse MJ, van Wering ER, Lankester AW, van Dongen JJ, Hoogerbrugge PM. van der Velden VH, et al. Among authors: willemse mj. Leukemia. 2001 Sep;15(9):1485-7. doi: 10.1038/sj.leu.2402198. Leukemia. 2001. PMID: 11516112 No abstract available.

9

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.

Boeckx N, Willemse MJ, Szczepanski T, van der Velden VH, Langerak AW, Vandekerckhove P, van Dongen JJ. Boeckx N, et al. Among authors: willemse mj. Leukemia. 2002 Mar;16(3):368-75. doi: 10.1038/sj.leu.2402387. Leukemia. 2002. PMID: 11896540

10

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.

van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: willemse mj. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page